![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/65 |
(11) | Number of the document | 2935319 |
(13) | Kind of document | T |
(96) | European patent application number | 13824203.7 |
Date of filing the European patent application | 2013-12-16 | |
(97) | Date of publication of the European application | 2015-10-28 |
(45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2013/060982 |
Date | 2013-12-16 |
(87) | Number | WO 2014/097113 |
Date | 2014-06-26 |
(30) | Number | Date | Country code |
201261738466 P | 2012-12-18 | US |
(72) |
Fornaro, Mara, CH
Glass, David, US
Jostock, Thomas, CH
Laux, Holger, CH
Romand, Sandrine, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | PRODUCTION OF THERAPEUTIC PROTEINS IN GENETICALLY MODIFIED MAMMALIAN CELLS |
PRODUCTION OF THERAPEUTIC PROTEINS IN GENETICALLY MODIFIED MAMMALIAN CELLS |